PharmaDesign Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

PharmaDesign General Information

Description

Developer of drugs intended for the pharmaceutical industry. The company develops products using information technology that utilizes bioinformatics and rational drug design technology focused on the proteins encoded in the human genome sequence, analyzes single nucleotide polymorphisms in the base sequence and then searches for disease-related genes and new splicing variants with physiological activity as well as offers drug discovery research tools such as databases, software and libraries.

Contact Information

Website
www.pharmadesign.co.jp
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 7th Floor, Wakamatsu Building
  • 3-3-6 Nihonbashihoncho, Chuo-ku
  • Tokyo, 103-0023
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
PeptiDream
Vertical(s)
Life Sciences
Corporate Office
  • 7th Floor, Wakamatsu Building
  • 3-3-6 Nihonbashihoncho, Chuo-ku
  • Tokyo, 103-0023
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaDesign Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaDesign‘s full profile, request access.

Request a free trial

PharmaDesign Patents

  • 81

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

PharmaDesign Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-5181156-B2 Casein kinase 1δ and casein kinase 1ε inhibitor Inactive 09-Aug-2010
JP-WO2012020726-A1 Casein kinase 1δ and casein kinase 1ε inhibitor Active 09-Aug-2010
JP-5794922-B2 1,3,4-oxadiazole-2-carboxamide compound Inactive 28-Dec-2009
JP-WO2011081205-A1 1,3,4-oxadiazole-2-carboxamide compound Active 28-Dec-2009
WO-2011081205-A1 1,3,4-oxadiazole-2-carboxamide compound Inactive 28-Dec-2009 C07D413/04
To view PharmaDesign’s complete patent history, request access »

PharmaDesign Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaDesign Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmaDesign‘s full profile, request access.

Request a free trial

PharmaDesign FAQs

  • When was PharmaDesign founded?

    PharmaDesign was founded in 1999.

  • Where is PharmaDesign headquartered?

    PharmaDesign is headquartered in Tokyo, Japan.

  • What is the size of PharmaDesign?

    PharmaDesign has 10 total employees.

  • What industry is PharmaDesign in?

    PharmaDesign’s primary industry is Drug Discovery.

  • Is PharmaDesign a private or public company?

    PharmaDesign is a Private company.

  • What is the current valuation of PharmaDesign?

    The current valuation of PharmaDesign is .

  • What is PharmaDesign’s current revenue?

    The current revenue for PharmaDesign is .

  • Who are PharmaDesign’s investors?

    Bio Frontier Partners has invested in PharmaDesign.

  • When was PharmaDesign acquired?

    PharmaDesign was acquired on 01-Oct-2015.

  • Who acquired PharmaDesign?

    PharmaDesign was acquired by PeptiDream.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process